A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance
Cited by 21
Related Papers
HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling
|Theranostics|2020|161
New insights into the correlations between circulating tumor cells and target organ metastasis
|Signal Transduction and Targeted Therapy|2023|134